These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 3437301

  • 41. Open, double-blind and long-term study of vigabatrin in chronic epilepsy.
    Reynolds EH, Ring HA, Farr IN, Heller AJ, Elwes RD.
    Epilepsia; 1991; 32(4):530-8. PubMed ID: 1868811
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Concentration gradients of free and total gamma-aminobutyric acid and homocarnosine in human CSF: comparison of suboccipital and lumbar sampling.
    Grove J, Schechter PJ, Hanke NF, de Smet Y, Agid Y, Tell G, Koch-Weser J.
    J Neurochem; 1982 Dec; 39(6):1618-22. PubMed ID: 7142991
    [Abstract] [Full Text] [Related]

  • 46. Schizophrenia, tardive dyskinesia, and brain GABA.
    Perry TL, Hansen S, Jones K.
    Biol Psychiatry; 1989 Jan 15; 25(2):200-6. PubMed ID: 2564786
    [Abstract] [Full Text] [Related]

  • 47. Immunocytochemical evidence that vigabatrin in rats causes GABA accumulation in glial cells of the retina.
    Neal MJ, Cunningham JR, Shah MA, Yazulla S.
    Neurosci Lett; 1989 Mar 13; 98(1):29-32. PubMed ID: 2710396
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Effect of vigabatrin on epilepsy in mentally retarded patients: a 7-month follow-up study.
    Matilainen R, Pitkänen A, Ruutiainen T, Mervaala E, Sarlund H, Riekkinen P.
    Neurology; 1988 May 13; 38(5):743-7. PubMed ID: 3362372
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. A multicentre study of vigabatrin for drug-resistant epilepsy.
    Browne TR, Mattson RH, Penry JK, Smith DB, Treiman DM, Wilder BJ, Ben-Menachem E, Miketta RM, Sherry KM, Szabo GK.
    Br J Clin Pharmacol; 1989 May 13; 27 Suppl 1(Suppl 1):95S-100S. PubMed ID: 2667606
    [Abstract] [Full Text] [Related]

  • 53. The irreversible gamma-aminobutyric acid (GABA) transaminase inhibitor gamma-vinyl-GABA blocks cocaine self-administration in rats.
    Kushner SA, Dewey SL, Kornetsky C.
    J Pharmacol Exp Ther; 1999 Aug 13; 290(2):797-802. PubMed ID: 10411594
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. [Gamma-vinyl GABA and tardive dyskinesia: a single-blind study versus placebo].
    Danion JM, Singer L, Tell G, Schechter P.
    Ann Med Psychol (Paris); 1984 Jan 13; 142(1):101-10. PubMed ID: 6476669
    [No Abstract] [Full Text] [Related]

  • 57. Vigabatrin increases human brain homocarnosine and improves seizure control.
    Petroff OA, Mattson RH, Behar KL, Hyder F, Rothman DL.
    Ann Neurol; 1998 Dec 13; 44(6):948-52. PubMed ID: 9851440
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.